Patent holdings for IPC class A61K 31/381

Total number of patents in this class: 3669

10-year publication summary

191
231
239
247
234
261
200
222
243
145
2017 2018 2019 2020 2021 2022 2023 2024 2025 2026

Principal owners for this class

Owner
All patents
This class
Allergan, Inc.
2155
67
Antecip Bioventures II LLC
381
58
The Regents of the University of California
20868
37
Janssen Pharmaceutica N.V.
3150
37
Sumitomo Pharma America, Inc.
70
27
Bristol-myers Squibb Company
4757
25
Novartis AG
10174
24
Takeda Pharmaceutical Company Limited
2698
23
LTS Lohmann Therapie-Systeme AG
679
22
Sunovion Pharmaceuticals Inc.
244
21
Boehringer Ingelheim International GmbH
4488
20
Centre National de La Recherche Scientifique
11092
19
Dana-Farber Cancer Institute, Inc.
2671
19
Institut National de La Sante et de La Recherche Medicale (inserm)
3295
19
Clexio Biosciences Ltd.
100
18
Astellas Pharma Inc.
1038
17
Shanghai Institute of Materia Medica, Chinese Academy of Sciences
876
17
The General Hospital Corporation
4881
16
Gilead Sciences, Inc.
2243
16
University of Pittsburgh - Of the Commonwealth System of Higher Education
3339
16
Other owners 3151